Bone Accretion in Adolescents Using the Combined Estrogen and Progestin Transdermal Contraceptive Method Ortho Evra: A Pilot Study

Journal of Pediatric and Adolescent Gynecology

Volumn 23, Issue 1, 2010, Pages 23-31

  Harel, Zeev ^a,b   Riggs, Suzanne ^a,b   Vaz, Rosalind ^a,b   Flanagan, Patricia ^a,b   Harel, Dalia ^a   Machan, Jason T ^c  

^a HASBRO CHILDREN'S HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

Adolescents; Bone; Bone mineral density; Ortho Evra; Transdermal contraception

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CALCIUM; CALCIUM CARBONATE; CENTRUM; ESTROGEN; ETHINYLESTRADIOL PLUS NORELGESTROMIN; GESTAGEN; INSULIN GROWTH FACTOR 1; MULTIVITAMIN; OSTEOCALCIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN; TUMS; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE ACCRETION; BONE DEMINERALIZATION; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; BONE MINERAL; CALCIUM INTAKE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNICITY; FEMALE; GROUPS BY AGE; GYNECOLOGICAL EXAMINATION; HIP; HORMONAL CONTRACEPTION; HUMAN; LUMBAR SPINE; MULTIPLE CYCLE TREATMENT; OSSIFICATION; OSTEOLYSIS; PHYSICAL ACTIVITY; PILOT STUDY; PRIORITY JOURNAL; TREATMENT DURATION; URINE;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ALKALINE PHOSPHATASE; BONE DENSITY; BONE DEVELOPMENT; CASE-CONTROL STUDIES; CHILD; COLLAGEN TYPE I; CONTRACEPTIVE AGENTS, FEMALE; DRUG COMBINATIONS; ETHINYL ESTRADIOL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NORGESTREL; OSTEOCALCIN; PEPTIDES; PILOT PROJECTS; SEX HORMONE-BINDING GLOBULIN; YOUNG ADULT;

EID: 72449128623     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2009.04.008     Document Type: Article

References (37)

1. Abrams L.S., Skee D., Natarajan J., et al. Pharmacokinetic overview of Ortho Evra/Evra. Fertil Steril 77 (2002) S3
2. Smallwood G.H., Meador M.L., Lenihan J.P., et al. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol 98 (2001) 799
3. Audet M.C., Moreau M., Koltun W.D., et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive: A randomized controlled trial. JAMA 285 (2001) 2347
4. Abrams L.S., Skee D.M., Natarajan J., et al. Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra/Evra) under conditions of heat, humidity, and exercise. J Clin Pharmacol 41 (2001) 1301
5. Sibai B.M., Odlind V., Meador M.L., et al. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). Fertil Steril 77 (2002) S19
6. Archer D.F., Bigrigg A., Smallwood G.H., et al. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women. Fertil Steril 77 (2002) S27
7. Abrams L.S., Skee D.M., Natarajan J., et al. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites. Br J Clin Pharmacol 53 (2002) 141
8. Zacur H.A., Hedon B., Mansour D., et al. Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions. Fertil Steril 77 (2002) S32
9. Zieman M., Guillebaud J., Weisberg E., et al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: analysis of pooled data. Fertil Steril 77 (2002) S13
10. Rubinstein M.L., Halpern-Felsher B.L., and Irwin C.E. An evaluation of the use of the transdermal contraceptive patch in adolescents. J Adolesc Health 34 (2004) 395
11. Harel Z., Riggs S., Vaz R., et al. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynecol 18 (2005) 85
12. Chetkowski R.J., Meldrum D.R., Steingold K.A., et al. Biologic effects of transdermal estradiol. N Engl J Med 314 (1986) 1615
13. Weissberger A.J., Ho K.K., and Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72 (1991) 374
14. Slowinska-Srzednicka J., Zgliczynski S., Jeske W., et al. Transdermal 17 beta estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor I in postmenopausal women. J Endocrinol Invest 15 (1992) 533
15. Kelly J.J., Rajkovic I.A., O'Sullivan A.J., et al. Effects of different oral estrogen formulations on insulin-like growth factor-I growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol (Oxf) 39 (1993) 561
16. Campagnoli C., Biglia N., Altare F., et al. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol 7 (1993) 251
17. Ljunghall S., Lindh E., and Johansson A.G. Endocrine interactions of insulin-like growth factor I on bone. Acta Paediatr Suppl 399 (1994) 178
18. Rosen C.J., Donahue L.R., and Hunter S.J. Insulin-like growth factors and bone: The osteoporosis connection. Proc Soc Exp Biol Med 206 (1994) 83
19. Ho K.K., and Weissberger A.J. Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res 7 (1992) 821
20. Warren M.P., Miller K.K., Olson W.H., et al. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and ostopenia: an open-label extension of a double blind, placebo-controlled study. Contraception 72 (2005) 206
21. Holioua L., and Anderson J.J. Lifetime calcium intake and physical activity habits: independent and combined effects on the radial bone of healthy premenopausal Caucasian women. Am J Clin Nutr 49 (1989) 534
22. Kasper M.J., Peterson M.G.E., Allegrante J.P., et al. Knowledge, beliefs, and behaviors among college women concerning the prevention of osteoporosis. Arch Fam Med 3 (1994) 696
23. Trends in oral contraceptive development and utilization looking to the future. Contracept Rep 7 (1997) 4
24. Polatti F., Perotti F., Filippa N., et al. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 51 (1995) 221
25. Cromer B., Stager M., Bonny A., et al. Depot Medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 35 (2004) 434
26. Ortho Evra (norelgestromin/ethinyl estradiol). US Food and Drug Administration Web site. Available at: http://www.fda.gov/cder/drug/infopage/othoevra/default.hum. Accessed November 11, 2008.
27. Wang Q., Nicholson P.H.F., Suuriniemi M., et al. Relationship of sex hormones to bone geometric properties and mineral density in early pubertal girls. J Clin Endocrinol Metab 89 (2004) 1698
28. Wang Q., Alén M., Nicholson P.H.F., et al. Differential effects of sex hormones on peri- and endocortical bone surfaces in pubertal girls. J Clin Endocrinol Metab 91 (2006) 277
29. Fortunati N., Fissore F., Fazzari A., et al. Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3′ 5′-monophosphate and protein kinase. Endocrinology 137 (1996) 686
30. Garnero P., Sornay-Rendu E., and Delmas P.D. Decreased bone turnover in oral contraceptive users. Bone 16 (1995) 499
31. Harel Z., Gold M., Cromer B., et al. Bone mineral density in postmenarchal adolescent girls in the United States: Associated biopsychosocial variables and bone turnover markers. J Adolesc Health 40 (2007) 44
32. Friend K.E., Hartman M.L., Pezzoli S.S., et al. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women-a clinical research center study. J Clin Endocrinol Metab 81 (1996) 2250
33. Bellantoni M.F., Vittone J., Campfield A.T., et al. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. J Clin Endocrinol Metab 81 (1996) 2848
34. Leonard M.B., Shults J., Wilson B.A., et al. Obesity during childhood and adolescence augments bone mass and bone dimensions. Am J Clin Nutr 80 (2004) 514
35. Klein K.O., Larmore K.A., de Lancey E., et al. Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab 83 (1998) 3469
36. Elgan C., Samsioe G., and Dykes A.K. Influence of smoking and oral contraceptives on bone mineral density and bone remodeling in young women: a 2-year study. Contraception 67 (2003) 439
37. Clark M.K., Sowers M.F., Dekordi F., et al. Bone mineral density and fractures among alcohol-dependent women in treatment and in recovery. Osteoporos Int 14 (2003) 396